Clean Science and Technology Limited
₹716.60-₹22.35 (-3.0%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹9,091 Cr
- P/E
- 30.9x
- EV / EBITDA
- 24.0x
- Revenue
- ₹922 Cr
- Net margin
- 31.4%
- ROCE
- 27.8%
Price chart
Technical chartScreen technicals →-29.4% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -9.7%
- 3M
- -1.6%
- 6M
- -12.5%
- 1Y
- -29.4%
- 5Y
- -65.4%
52-week range
Day change -₹22.35 (-3.0%) from ₹739 to ₹717 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in CLEAN, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Healthy return on equity of 20.4%
Concerns0
Rule-based from financial data. Not advice.
About the company
Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the Americas, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharmaceutical & Agro Intermediates segments.
Read moreShow less
Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the Americas, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharmaceutical & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, tertiary butyl hydroquinone, hindered amine light stabilisers, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean light stab 770, 4-hydroxy tempo, l-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, and dimethyl sebacate. It also provides FMCG chemicals, such as 4-methoxy acetophenone, anisole, guaiacol, butylated hydroxy anisole, l-ascorbyl palmitate, tertiary butyl hydroquinone, para di-methoxy benzene, and ortho methoxy toluene. In addition, the company offers pharmaceutical and agro intermediates, which include guaiacol, dicyclohexyl carbodiimide, veratrole, DHDT, para benzoquinone, para di-methoxy benzene, anisole, and ortho methoxy toluene. It exports its products and serves polymers, coatings, food, automotive, construction, cosmetics, personal care, fragrances, pharmaceuticals, agrochemical manufacturers, specialty chemical firms, and other industries. The company was incorporated in 2003 and is headquartered in Pune, India.
- Sector
- Materials
- Shares outstanding
- 10.6 Cr shares
- ISIN
- INE227W01023
- BSE code
- 543318
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹9,091 Cr
- P/E
- 30.9x
- P/B
- 5.9x
- EV / EBITDA
- 24.0x
- EV / Sales
- 11.4x
- P/S
- 11.5x
- Earnings yield
- 3.2%
- 52-week high
- ₹1,063.10
- 52-week low
- ₹656.70
Profitability
- Operating margin
- 42.8%
- Net margin
- 31.4%
- EBITDA margin
- 47.7%
- ROE
- 20.4%
- ROCE
- 27.8%
- ROA
- 18.1%
- Dividend payout
- 21.0%
- Tax rate
- 25.0%
- Other income, % of PBT
- 11.5%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹922 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 16.9%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 13.5%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹376 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -14.9%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 17.7%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 12.1%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹277 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -7.4%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹6.00 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 18.3%
Solvency and efficiency
- Current ratio
- 6.29
- Debt / Equity
- 0.00
- Debt / Assets
- 0.00
- Debt / EBITDA
- 0.00
- Interest coverage
- 338.00
- Financial leverage
- 1.13
- CFO / Net profit
- 1.12
- Cash / Market cap
- 3.3%
- Cash per share
- ₹28.40
- Asset turnover
- 0.58
- Fixed asset turnover
- 1.97
- Capital intensity
- 0.51
- Debtor days
- 75 days
- Inventory turnover
- 2.50
- Cash conversion cycle
- 100 days
Where the revenue went
Of every ₹100 of FY2025 revenue, ₹32 was left as net profit.
| From | To | Amount |
|---|---|---|
| Sales | Expenses | ₹522 Cr |
| Sales | Operating profit | ₹400 Cr |
| Operating profit | Interest | ₹1 Cr |
| Operating profit | Depreciation | ₹44 Cr |
| Operating profit | Profit before tax | ₹355 Cr |
| Other income | Profit before tax | ₹36 Cr |
| Profit before tax | Tax and other | ₹99 Cr |
| Profit before tax | Net profit | ₹292 Cr |
Revenue and net profit
Revenue grew 16.9% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹512 Cr | ₹198 Cr |
| FY2022 | ₹685 Cr | ₹229 Cr |
| FY2023 | ₹936 Cr | ₹304 Cr |
| FY2024 | ₹789 Cr | ₹248 Cr |
| FY2025 | ₹922 Cr | ₹292 Cr |
Cash flows
FY2025: ₹279 Cr from operations, ₹58.0 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹193 Cr | ₹7 Cr |
| FY2022 | ₹127 Cr | ₹3 Cr |
| FY2023 | ₹299 Cr | ₹54 Cr |
| FY2024 | ₹277 Cr | ₹49 Cr |
| FY2025 | ₹279 Cr | ₹58 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹922 Cr+16.9%1Y
- Net profit
- ₹292 Cr+17.7%1Y
- Cash from operations
- ₹279 Cr
- Free cash flow
- ₹58 Cr+18.4%1Y
- Revenue CAGR, 5Y
- 13.5%
- EBITDA CAGR, 5Y
- 13.8%
- Net profit CAGR, 5Y
- 12.1%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹922 Cr | ₹400 Cr | — | ₹292 Cr | ₹279 Cr | ₹58 Cr | 20.0% | +16.9% | +17.7% |
Monthly returns
Month-by-month returns of CLEAN across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹1,605 Cr |
| Equity capital | ₹11 Cr |
| Reserves | ₹1,446 Cr |
| Borrowings | ₹1 Cr |
| Other liabilities | ₹147 Cr |
| Assets | ₹1,605 Cr |
| Fixed assets | ₹364 Cr |
| Capital work in progress | ₹4 Cr |
| Investments | ₹907 Cr |
| Other assets | ₹330 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
CLEAN trades at 30.9x earnings against a peer median of 35.5x (a 13% discount).
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Clean Science and Technology LimitedCLEANthis companyP/E ↓ discount | ₹9,091 Cr | 30.9x | 5.9x | 20.4% | 24.0x |
| Supreme Petrochem Ltd.SPLPETRO | ₹10,605 Cr | 34.5x | 4.8x | — | — |
| PRIVI SPECIALITY CHEMICALS LIMITEDPRIVISCL | ₹10,554 Cr | 37.8x | 8.4x | 10.7% | 32.1x |
| JK Lakshmi Cement LimitedJKLAKSHMI | ₹9,438 Cr | 20.4x | 2.5x | 14.9% | 9.9x |
| Star Cement LimitedSTARCEMENT | ₹8,666 Cr | 270.0x | 5.3x | 13.1% | 19.9x |
| Alkyl Amines Chemicals Ltd.ALKYLAMINE | ₹8,244 Cr | 45.2x | 5.7x | 11.8% | 30.7x |
| Ashapura Minechem LtdASHAPURMIN | ₹8,147 Cr | 57.9x | 20.5x | 83.4% | 46.1x |
| Birla Corporation Ltd.BIRLACORPN | ₹8,110 Cr | 28.4x | 1.4x | 3.5% | 14.0x |
| Kirloskar Ferrous Industries Ltd.KIRLFER | ₹7,675 Cr | 22.2x | 2.1x | 9.9% | 10.2x |
| Peer median | — | 35.5x | 3.7x | 12.9% | 19.2x |
Year-to-date ROI
CLEAN since 1 January, against earlier years.
Historical volatility
CLEAN's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 51.0% |
| FY2022 | 44.0% |
| FY2023 | 43.0% |
| FY2024 | 43.0% |
| FY2025 | 43.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹922 Cr |
| Costs | |
| Interest | ₹1 Cr |
| Expenses | ₹523 Cr |
| Operating profitOperating Profit | ₹400 Cr |
| Other income and charges | |
| Profit before tax | ₹391 Cr |
| Tax | |
| Net profitNet Profit | ₹292 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹1,605 Cr |
| Equity capitalEquity Capital | ₹11 Cr |
| Reserves | ₹1,446 Cr |
| Borrowings | ₹1 Cr |
| Other liabilitiesOther Liabilities | ₹147 Cr |
| AssetsTotal Assets | ₹1,605 Cr |
| Fixed assetsFixed Assets | ₹364 Cr |
| Capital work in progressCWIP | ₹4 Cr |
| Investments | ₹907 Cr |
| Other assetsOther Assets | ₹330 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹279 Cr |
| Investing cash flowCash from Investing Activity | -₹221 Cr |
| Financing cash flowCash from Financing Activity | -₹52 Cr |
| Change in cashNet Cash Flow | ₹6 Cr |
Learn while you research
Academy chapters picked for Clean Science and Technology Limited and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 30.9, learn when high multiples are justified.6 min read
- 04 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 05 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read